Abeona Therapeutics develops cell and gene therapies for serious diseases, targeting both patients and the healthcare sector.
abeonatherapeutics.comLinkedInClevelandBiotechFounded 2013Public company
2 sources
Sources agree. The release calls the financing “foundation-led,” but does not identify a specific lead investor; foundations described as providing support rather than investments are excluded.
2 sources
The release's “more than $2 million” refers to cumulative funding raised to date, not the amount of this seed round.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Funding round [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $3.6M | 2014-12-01 | not stated | No recent discussion |
2 sources [ VERIFIED · CORRECTED ] read against 2 sources
Sources agree. The release calls the financing “foundation-led,” but does not identify a specific lead investor; foundations described as providing support rather than investments are excluded. | ||||
Abeona Therapeutics is a commercial-stage biopharmaceutical company developing and delivering cell and gene therapies for serious diseases with high unmet need.
| Seed [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $750K $2M to date | 2013-12-16 | not stated | No recent discussion |
2 sources [ VERIFIED · CORRECTED ] read against 2 sources
The release's “more than $2 million” refers to cumulative funding raised to date, not the amount of this seed round. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]2 pages read: investors.abeonatherapeutics.com, prnewswire.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 2 sources·[ BRANDING ]logo and colour from the homepage·[ AGENT ]company research by the Firecrawl agent | ||||